Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC); Notice of Charter Renewal, 77843 [2022-27481]

Download as PDF 77843 Federal Register / Vol. 87, No. 243 / Tuesday, December 20, 2022 / Notices information collection request (ICR) titled ‘‘Awardee Lead Profile Assessment (ALPA)’’ (OMB Control No. 0920–1215; Exp. Date 03/31/2024). The goal of this ICR is to build on the CDC’s existing childhood lead poisoning prevention program. CDC requires that ongoing and new CDC Childhood Lead Poisoning Prevention Programs (CLPPPs), including the FY21 ‘‘Childhood Lead Poisoning Prevention and Surveillance of Blood Lead Levels in Children’’ (CDC–RFA–EH21–2102), complete the ALPA annually. This annual information collection will be used to identify jurisdictional legal frameworks governing CDC-funded childhood lead poisoning programs (CLPPPs) in the United States and strategies for implementing childhood will be eliminated. This program management survey has been revised in several ways, including the addition of new answer options and questions to understand usage of the updated blood lead reference value (BLRV). The time per response is the same from the 2021 estimate (47 minutes per response) despite revisions to the survey. This updated estimate is based on recent pilot tests of the revised survey among nine respondents, and includes the time needed to review the ALPA Training Manual. CDC is requesting OMB approval for a total time burden of 59 hours and a total number of 75 respondents per year. These estimates remain unchanged from the previous PRA clearance. lead poisoning prevention activities. CDC will use this information to inform guidance, resource development, and technical assistance activities in support of the ultimate goal, which is eliminating lead exposure in children. The dissemination of these ALPA results will ensure that both funded and non-funded jurisdictions are able to: (1) identify policies and other factors that support or hinder childhood lead poisoning prevention efforts; (2) understand what strategies are being used by funded public health agencies to implement childhood lead poisoning prevention activities; and (3) use this knowledge to develop and apply similar strategies to support the national agenda to eliminate childhood lead poisoning. CDC will now use one data collection mode, a web survey. Reporting via email ESTIMATED ANNUALIZED BURDEN HOURS Number of responses per respondent Average burden per response (in hours) Total burden hours Form name State or Local Governments (or their bona fide fiscal agents). ALPA Web Survey ........................... 75 1 47/60 59 Total ........................................... .......................................................... ........................ ........................ ........................ 59 Jeffrey M. Zirger, Lead, Information Collection Review Office, Office of Scientific Integrity, Office of Science, Centers for Disease Control and Prevention. [FR Doc. 2022–27508 Filed 12–19–22; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC); Notice of Charter Renewal Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of charter renewal. AGENCY: This gives notice under the Federal Advisory Committee Act of October 6, 1972, that the Centers for Disease Control and Prevention (CDC)/ Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC), Centers for Disease Control and SUMMARY: lotter on DSK11XQN23PROD with NOTICES1 Number of respondents Type of respondent VerDate Sep<11>2014 18:41 Dec 19, 2022 Jkt 259001 Prevention, Department of Health and Human Services, has been renewed for a 2-year period through November 25, 2024. FOR FURTHER INFORMATION CONTACT: CAPT Deron Burton, MD, JD, MPH, Acting Designed Federal Officer, Centers for Disease Control and Prevention (CDC)/Health Resources and Services Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and STD Prevention and Treatment (CHAC), CDC, HHS, 1600 Clifton Road, NE, Mailstop US8–6, Atlanta, Georgia 30329–4027; Telephone (404) 639–1506; Email: DBurton@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2022–27481 Filed 12–19–22; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00057 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention [Docket No. CDC–2022–0014] Record of Decision for the Final Supplemental Environmental Impact Statement for the Roybal Campus 2025 Master Plan; Correction Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: General notice. AGENCY: On November 17, 2022, the Centers for Disease Control and Prevention (CDC), within the Department of Health and Human Services (HHS), published a notice in the Federal Register announcing the Record of Decision (ROD) for the Final Supplemental Environmental Impact Statement (SEIS) for CDC’s Roybal Campus in Atlanta, Georgia. In the Decision section of the notice, the description of the incinerator was incorrect. FOR FURTHER INFORMATION CONTACT: Thayra Riley, NEPA Coordinator, Office of Safety, Security, and Asset Management, Centers for Disease Control and Prevention, 1600 Clifton SUMMARY: E:\FR\FM\20DEN1.SGM 20DEN1

Agencies

[Federal Register Volume 87, Number 243 (Tuesday, December 20, 2022)]
[Notices]
[Page 77843]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-27481]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Centers for Disease Control and Prevention (CDC)/Health Resources 
and Services Administration (HRSA) Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment (CHAC); Notice of Charter 
Renewal

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of charter renewal.

-----------------------------------------------------------------------

SUMMARY: This gives notice under the Federal Advisory Committee Act of 
October 6, 1972, that the Centers for Disease Control and Prevention 
(CDC)/Health Resources and Services Administration (HRSA) Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment 
(CHAC), Centers for Disease Control and Prevention, Department of 
Health and Human Services, has been renewed for a 2-year period through 
November 25, 2024.

FOR FURTHER INFORMATION CONTACT: CAPT Deron Burton, MD, JD, MPH, Acting 
Designed Federal Officer, Centers for Disease Control and Prevention 
(CDC)/Health Resources and Services Administration (HRSA) Advisory 
Committee on HIV, Viral Hepatitis and STD Prevention and Treatment 
(CHAC), CDC, HHS, 1600 Clifton Road, NE, Mailstop US8-6, Atlanta, 
Georgia 30329-4027; Telephone (404) 639-1506; Email: [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-27481 Filed 12-19-22; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.